Is resistance useless? Multidrug resistance and collateral sensitivity
- 31 October 2009
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 30 (10), 546-556
- https://doi.org/10.1016/j.tips.2009.07.003
Abstract
No abstract availableKeywords
This publication has 126 references indexed in Scilit:
- Structure of a multidrug transporterNature Biotechnology, 2009
- Synthesis, Activity, and Pharmacophore Development for Isatin-β-thiosemicarbazones with Selective Activity toward Multidrug-Resistant CellsJournal of Medicinal Chemistry, 2009
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug BindingScience, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)Biochemical Pharmacology, 2007
- A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeuticsProceedings of the National Academy of Sciences of the United States of America, 2006
- Selective Toxicity of NSC73306 in MDR1-Positive Cells as a New Strategy to Circumvent Multidrug Resistance in CancerCancer Research, 2006
- Screening of an annotated compound library for drug activity in a resistant myeloma cell lineCancer Chemotherapy and Pharmacology, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005